Friday, December 17, 2021 7:10:32 PM
The biological Inovio arrives in Veracruz as a high-tech and effective alternative against Covid-19, therefore, Comprehensive Counseling Training for the Clinical Research Center (FAICIC) will have 250 antigens to apply to the same number of 18-year-olds in Go ahead that they have never been vaccinated against the coronavirus, nor are they pregnant or are currently breastfeeding; as well as those who suffer from chronic diseases such as: diabetes, hypertension, cancer, HIV, obesity, with allergies, among others.
The general director of the Faicic Clinical Research Center, Sharzy Molina Guízar, explained that it is a very safe antigen, which has the characteristic that it is not injected, but through a shot in the arm that will impact at the cellular level, by means of a electrode, as it has a very different molecular composition that makes it different from those already known, because it travels at the cellular level, causing immunity in 24 hours, longer and more efficiently.
“Previous vaccines were given through an injection in the arm; This also goes in the arm, but it is done by means of a device that is like a pistol, which what it does is that here in the arm, in the muscle, a shot is fired that does not cut, that does not open the skin, It does not hurt, it is painless and this allows it to travel at the cellular level and how do we achieve immunity in 24 hours? We achieve this because it travels so fast in the cells that what it does is a reproduction, they cause an excitation to the cells that make one infect the other very quickly and, then, we can go from one to 10, from 10 to 100 , from 100 to a thousand and we not only cause an immunity for a longer time, but also, much more effective ”.
He explained that Inovio decided to do it this way, since the existing vaccines that are applied in the injected arm, its route at the muscular level generated an immunity of 28 to more than 40 days, depending on the organism, due to its composition and its journey in the body, which also caused other allergic reactions or altered some parts of the body, while Inovio causes immediate immunity.
Likewise, Molina Guízar recognized that, based on studies carried out, Inovio has a high proven efficacy against the Ómicron variant, although investigations continue, which is why it adds to the list of qualities of this antigen.
“This vaccine, so far, is showing an efficacy of 95.5% in the first application that is given at 24 hours. This vaccine has two doses (two applications): on day zero, which is the day the vaccine is applied, and at 28 days, ”said the interviewee.
The general director of Faicic admitted that there are side effects similar to those of injected vaccines, such as: headache, nausea, dizziness, weakness, fever, among others, which are treatable and will be treated by the medical staff of the center of research.
In this sense, he recognized that there is still a large number of the population not vaccinated against this disease for various reasons, such as: fear, resistance, lack of information, among others.
“After two years, we already have a lot of experience, we have seen how to improve it and we invited the population that was afraid to come because now we have a very safe vaccine; It is also aimed at those people who, for example, who are allergic, who have chronic degenerative diseases ”.
Sharzy Molina highlighted that they will be working every day for the application of Inovio, including holidays such as December 25 and January 1, 2022, for which, he invited citizens with these characteristics to register in this application, since It will serve the Veracruz and foreign population, where in the case of the latter, they will be supported with the transfer, therefore, they require social leaders who support with this process the population of marginalized areas whose expenses are assumed by Faicic.
Inovio vaccine arrives in Veracruz, with immunity in 24 hours from the 1st dose
He added that in addition to the support for the transfer to the Faicic headquarters, the patients will be provided with: medical, nutritional, psychological consultation, laboratory studies and for a year and a half they will remain in contact with them, with open consultation for any subsequent symptom or condition that they may present.
He recalled that Faicic is a research center that seeks to improve people's health and lives, through studies and in coordination with recognized pharmaceutical companies.
Interested parties may access the website: https://faicic.com.mx/formulario_covid.php, on their social networks on Facebook such as https://www.facebook.com/Faicic and instagram; Likewise , they can call the phone: 2299327808 .
https://www-eldictamen-mx.translate.goog/noticias-de-veracruz/boca-ver/llega-a-veracruz-vacuna-inovio-con-inmunidad-en-24-horas-desde-la-1a-dosis/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en
Recent INO News
- INOVIO to Present at Upcoming Scientific Conference • PR Newswire (US) • 09/17/2024 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 10:22:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:06:54 AM
- INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/08/2024 08:05:00 PM
- INOVIO Reports Inducement Grant Under Inducement Plan • PR Newswire (US) • 08/01/2024 08:05:00 PM
- Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 • PR Newswire (US) • 07/25/2024 08:05:00 PM
- INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 • PR Newswire (US) • 07/25/2024 12:00:00 PM
- INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway • PR Newswire (US) • 07/11/2024 12:00:00 PM
- INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer • PR Newswire (US) • 07/02/2024 08:05:00 PM
- INOVIO Reports Inducement Grant Under Inducement Plan • PR Newswire (US) • 07/01/2024 08:00:00 PM
- INOVIO Added to Russell 2000® Index Effective July 1, 2024 • PR Newswire (US) • 07/01/2024 12:00:00 PM
- INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. • PR Newswire (US) • 06/04/2024 12:00:00 PM
- INOVIO Reports Inducement Grants Under Inducement Plan • PR Newswire (US) • 05/31/2024 08:48:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:01:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:50:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:50:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:49:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:13:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:12:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:11:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:10:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM